Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-06

FDA Approved: RIBAVIRIN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for ribavirin from Aurobindo Pharma Limited, authorizing continued approval and use of the ribavirin product under the a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ribavirin (ribavirin)

Snippet

SUPPL AP for RIBAVIRIN (RIBAVIRIN)